Associate Professor
University of North Carolina at Chapel Hill
Nilu Goonetilleke is currently an Associate Professor at the University of North Carolina. She completed her undergraduate and honors training at the University of Queensland, studying macrophage biology in the laboratory of David Hume. She then moved to the laboratory of Adrian Hill at the University of Oxford completing a PhD in M. tuberculosis T cell immunity. During her PhD, she developed novel T cell vaccine regimens against tuberculosis that successfully advance through to clinical testing in humans . She next joined Andrew McMichael’s group, also at Oxford, where as an investigator in the Center for HIV/AIDS Vaccine Immunology her research focused on T cell-mediated control of HIV. Research in the Goonetilleke UNC lab (G-lab) aims to better understand how T cell immunity differentially contributes to control of infectious disease in humans. She is currently leading first-in-human trials testing HIV T cell vaccines aimed at augmenting anti-HIV immunity in people living with HIV.
Disclosure information not submitted.
Wednesday, January 12, 2022
2:15 PM – 3:15 PM ET
.png)